1 Min Read
Sept 1 (Reuters) - Novartis AG
* Says it has received EU approval for tafinlar and mekinist, the first combination approved for aggressive form of melanoma Source text for Eikon: Further company coverage: (Reporting By Zurich Slot)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.